Since scientists discovered HIV/AIDS in the early 1980s, the virus and resulting disease have had a growing influence on the current disability discrimination regime. The laws of the United States have recognized that HIV is a disability, and that those living with its effects should receive the same protections as other disabled individuals. The medical community has played a significant role in this development.
The medical community has moved past its negative history with AIDS; a period of misinformation that fed a sensationalist media by first characterizing HIV/AIDS as the "Gayrelated immune deficiency", or "GRID." This community has developed treatments that show HIV is a disability that can be managed. The medical community has also worked with the Centers for Disease Control in establishing as a matter of law that HIV is not a "communicable disease," which has had a significant effect on the "direct threat" defense for discriminatory practices.
Although the legal system has treated sympathetic plaintiffs such as Ryan White with candor, many issues surrounding HIV discrimination remain unresolved. Specifically, the legal system has not developed an adequate method of analysis to confront the difficult issues of confidentiality and patient safety in situations where treating medical practitioners are HIVpositive.
In this paper I evaluate current regulation of HIV positive Medical Care Workers (MCWs). I do so by exploring relevant statutes and case law, federal regulations, and professional association measures. I do not distinguish between each practice area of the medical profession; this would have the reader losing the forest for the trees. Rather, in this paper I explore issues of discrimination against all HIV-positive MCWs, from nurses and dental assistants to cardiovascular surgeons.
After depicting the history of HIV and its effect on U.S. law, I address the issue of confidentiality, which has been at the forefront of discrimination cases. I also examine current disclosure requirements between MCWs and employers, employers and patients, and MCWs and patients, and discuss the implications of such requirements. Moving on from confidentiality, I
delve into the difficulty that employers have in balancing patient safety and discriminatory practices. After tackling confidentiality and disclosure, I suggest a process whereby the rules can be clarified, patient safety can be ensured, and discrimination can be drastically reduced.
II. BACKGROUND
HIV has not only destroyed lives through its devastating physical and emotional tolls, but through a misguided public perception that has led to immeasurable consequences. Though management of the virus and resulting disease AIDS have improved drastically since they were discovered in the early 1980s, the American public has held fast to its stereotypes of the disease.
Despite the force and effect of disability discrimination legislation in the form of The Rehabilitation Act of 1973 and the Americans with Disabilities Act, individuals with HIV have faced an unrelenting barrage of discrimination by a society that insists on handling them with a glove and tongs. This section will unveil the history of HIV, convey relevant disability discrimination legislation and case law, and detail the law's treatment of HIV-positive MCWs.
A. THE HIV OUTBREAK
Doctors discovered HIV/AIDS through a series of diagnoses surrounding a rare opportunistic infection, which seemed only to afflict needle users and gay men. The infection,
Pneumocystis carinii pneumonia ("PCP"), typically occurs in people with compromised immune systems. 2 On the heels of the PCP diagnoses came another series of diagnoses, this time a type of cancer known as Kaposi's Sarcoma, which also appeared to be clustering in needle users and gay men. 3 Members of the press took notice of the illnesses and began using the term "GRID,"
standing for "gay-related immune deficiency." 4 By 1982, the Centers for Disease Control had determined that a more appropriate name for the disease was "AIDS," or "acquired immunodeficiency syndrome."
5
Although the origin of HIV/AIDS was long the subject of debate, it has been widely recognized that the virus originated in West African chimpanzees. 6 In 1999, the National
Institutes of Health presented in a press release the findings of an international team of researchers charged with discovering the origins of HIV. The findings stated:
We now have chimpanzee isolates of simian immunodeficiency virus [SIVcpz] that have been shown by careful molecular analysis to be closely related to HIV-1. Furthermore, this virus infects a primate species that is 98 percent related to humans. This may allow us -if done carefully and in collaboration with primatologists working to protect this endangered species -to study infected chimpanzees in the wild to find out why these animals don't get sick, information that may help us better protect humans from developing AIDS.
7
The experts determined that the simian immunodeficiency virus was likely introduced to the human bloodline when hunters were exposed to infected blood of the subspecies Pan troglodytes troglodytes.
8
Although AIDS is often known as a child of the 1980s, societal perception of the disease and maturity regarding the treatment of those affected by it has seen stunted growth.
Misunderstanding and poor education regarding methods of transmission, disease management, and affected groups has plagued advocates and sufferers alike. Mauro poses some risk. It is not ontologically impossible for him to transmit a disease of very great lethality. However, the chance that he will do so to any given patient is "small." Whether we call the risk "extremely small," "vanishingly small," "negligible," or whatever, assessing the risk remains a judgment that must be made by considering both the actual probability of harm and the degree of the consequences, just as the Supreme Court instructed us…That is what the District Court did not do, and that is why I would reverse its decision and remand for reconsideration under the correct standard-a full assessment of both the risk and the consequence. 59 Judge Boggs was dissatisfied with the subjective determination that this HIV-positive surgical technician posed a direct threat to patients, and argued for an objective legal determination. 60 Though Judge Boggs argued persuasively in his dissent, he was unable to sway the outcome of the case.
B. HIV AS A DISABILITY
In keeping with the trend set by the Fourth and Sixth Circuits, the Eleventh Circuit also found against an HIV-positive MCW in a 2001 decision, Waddell v. Valley Forge Dental. 61 In
Waddell, the court relied heavily on the four Arline factors 62 for analyzing risk, paying particular attention to the fourth factor dealing with the probability of HIV transmission between MCW and patient. 63 The holding states:
In summary, several factors, when taken together, indicate that Waddell poses a significant risk to others in the workplace: the use of sharp instruments by dental hygienists; routine patient bleeding during dental work; the risk that hygienists will be stuck or pricked while using an instrument; the statements of Waddell and medical his (sic) experts acknowledging that there is some risk, even if theoretical and small, that blood-to-blood contact between hygienist and patient can occur; and the possibility of an inadvertent bite or other accident during a dental cleaning. These "particularized facts" provide "the best available objective evidence" that Waddell, because he is infected with the fatal, contagious disease of HIV, is a direct threat to his workplace, and therefore not a qualified individual under the ADA.
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The Waddell holding, though damning to HIV-positive MCWs, is likely the clearest articulation of how courts view this issue, and how they will continue to decide in future cases.
Despite admission by the legal community that HIV positive individuals are disabled under the Americans with Disabilities Act, whether experiencing symptoms or asymptomatic, the courts have made the distinction that Medical Care Workers are subject to a much higher level of scrutiny. Absent a successful challenge at the Supreme Court level, it appears that this trend will go unchanged.
III. REGULATION OF HIV-POSITIVE MCWs
63 "At the heart of this case, however, is the district court's analysis of the fourth factor delineated in Arline, the probability of HIV transmission between a dental hygienist and patient. 71 Although subsequent discussion and opinions flourished as to how Kimberly Bergalis and the other patients were actually infected with the HIV virus, the relative certainty that the infection came from Dr. Acer and his use of safety measures are evidence of a failure in the regulatory regime at that time.
Additionally, the case of Kimberly Bergalis is an unfortunate case study in the imbalance of power between MCWs and patients, and the importance that disclosure plays in preventing the transmission of HIV in medical procedures.
Though I do not want to devote too much time to one occupation, the doctor-patient relationship provides the best look at the issues of MCW-patient relationships because of both the width and depth of available information. Because doctors spend a significant amount of time with their patients collecting information through medical interviews and conversations, 72 it is no surprise that this aspect of the relationship has been given significant pedagogical treatment.
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The medical interview, like many legal concepts, has both substantive and procedural components. 74 The following chart depicts those components: The expectation of privacy is one of the most important aspects of the doctor-patient relationship and influences the disposition to trust, but confidentiality is no longer solely in the doctor's control. Organizational personnel have access to patient information and must be required to keep it private, taught how to keep it private and monitored to be sure they do. 77 See Goold, supra note 62.
78 Brody H. The Healer's Power. New Haven, Conn: Yale University Press; 1992.
79 See Goold, supra note 62 80 Id.
is stored --including hospitals, doctor and dental offices, and psychiatric facilities --is wrought with opportunity for both voluntary and involuntary disclosure of confidential information.
Although the medical community rightfully puts the patients first, MCWs also carry around sensitive information about themselves (their own prescriptions, medical documents, insurance forms). If a patient sees a doctor take an HIV medication, what duty does the patient have to that doctor? If a patient overhears a phone call their dental hygienist just had about his CD4+ T cell count, can the patient request a different hygienist? I will address disclosure requirements presently.
B. DISCLOSURE REQUIREMENTS
The hypotheticals I just posed bring to surface a critical issue for MCW confidentiality. The first clause of this policy seems reasonable at first blush. After all, all HIV-positive tests are reported to government agencies to ensure public safety, and requiring doctors to report to local public health officials is in accordance with this purpose. However, requiring an HIV-positive doctor, or MCW, to report to a local review committee could be viewed as an infringement of that individual MCW's right to confidentiality of their sensitive medical information.
The AMA appears to backtrack from its disclosure requirement in H-20.912(7), which states:
H-20.912(7) -Liability Coverage for HIV-Infected Physicians. Our AMA will continue the dialogue with liability insurance companies to monitor issues surrounding liability coverage for HIV-infected physicians and will establish guidelines for any collection or use of HIVserostatus data by professional liability carriers. Serostatus information should be treated with strict privacy and nondisclosure assurances.
Discussions with liability insurance companies should include the position that to date there are no scientific grounds to require testing of physicians for HIV status. inappropriately expanded to require disclosure of a physician's impairment… or information 83 Id. at H-20.912(7) (emphasis added).
otherwise protected by laws governing patient privacy and confidentiality." 84 Here, the AMA absolves itself of any legal duty to protect a physician's right to privacy or confidentiality.
In a Pennsylvania court case, In re Application of Milton S. Hershey Medical Center of
Pennsylvania State University, the Supreme Court of Pennsylvania addressed disclosure requirements of HIV-positive physicians within its jurisdiction. 85 In that case, the court determined that a physician who had contracted HIV 86 and who could have conceivably had blood contact with several hundred patients was subject to an order by the trial court requiring limited disclosure of Dr. Doe's HIV status for "compelling need" under the Confidentiality of HIV-Related Information Act. 87 The Pennsylvania Supreme Court, recognizing the high burden of proof required by the petitioners, and balancing Dr. Doe's privacy interests with the safety interests of the hospitals and patients involved, determined that the trial court did not abuse its discretion in granting such an order. 88 Although this case has limited application because it is a state (commonwealth) Supreme Court decision, it is instructive as to the way the scales of justice will tip when courts weigh HIV-serostatus disclosure against public safety.
Although the AMA takes weak positions with respect to protecting physicians', and likewise MCWs' rights, their instincts are correct. HIV-positive MCWs performing invasive procedures should be subject to some form of regulation, and patient consent should also be a critical aspect to approving whether or not that MCW may perform the procedure. However, 84 Id. at D-315.993 (emphasis added). 85 Application of Milton S. Hershey Med. Ctr. of Pennsylvania State Univ., 535 Pa. 9, 11, 634 A.2d 159, 160 (1993) 86 Id. at 11 (stating that the method by which Dr. Doe contracted HIV was no determinable). 87 Id. (interpreting the Confidentiality of HIV-Related Information Act (HIV Act), 35 P.S. § 7608(a)(2)). 88 Id. at 13-14.
further legislative instruction at the federal level must be carefully crafted so as to correct the unbalanced disclosure requirements which place a high burden on HIV-positive MCWs.
IV. ANALYSIS A. DEFICIENCIES IN THE CURRENT REGIME REGULATING HIV-POSITIVE MCWs
Although the previous sections laid out the deficiencies of the current regulatory regime pertaining to HIV-positive MCWs, I will briefly restate them in the order that they will be MCWs' right to privacy and confidentiality in their medical information. These three issues will be the subject of my analysis.
B. RECOMMENDATIONS TO PROTECT THE RIGHTS OF HIV-POSITIVE MCWs AND ENSURE PATIENT SAFETY
With respect to the first two issues I laid out pertaining to the ADA's deficiencies and the courts' reluctance to side with HIV-positive MCWs, two birds can be killed with one stone:
either an amendment to the Americans with Disabilities Act or a new piece of legislation protecting HIV-positive MCWs. Because judges tend to adhere to stare decisis, both for consistency in applying the law and the fear of being reversed on appeal, The Americans with Disabilities Act will most likely continue to fail in federal court as defense to disability discrimination against HIV-positive MCWs. However, new legislative language tailored to this specific issue could prevent both the discriminatory practices that land parties in court, and ensure that courts are applying a fair law, and applying it fairly. For the purpose of further analysis, I will not focus on whether the changes should be made to the ADA or as a separate law.
The new legislative language must be consistent with the legislative scheme protecting This class of protected MCWs must be given protection from unnecessary disclosure of their HIV-serostatus, whether this disclosure would be explicitly or implicitly required. Because of the stigma that still exists and remains attached to those with HIV, this disclosure must be treated with the sensitivity that the disease itself requires. However, to discuss disclosure, I will move to the third issue I raised in the previous section. That is, the MCW-patient relationship.
The MCW-patient relationship must necessarily be a two-way street. It must be so to ensure effective communication, develop and facilitate the trust needed to provide proper care, and prevent doing harm. One way to restore this balance without requiring disclosure by an individual HIV-positive MCW would involve a specific HIV-waiver 89 provided to patients. This waiver would be required by my proposed legislation. This waiver would be presented to patients much as any other waiver is presented, although there would be mandatory explanation of the waiver. Additionally, no patient would be declined care for declining to sign the waiver (I will get to this in a moment). This waiver would state, if answered affirmatively, that the patient recognizes that some MCWs at the particular facility may be HIV-positive, and that they permit Signature: ______________________________ Date: ______________________________
